Table 1 Patient Characteristics
Characteristic | Value |
|---|---|
General information | |
 Patient sex | |
  Male | 22 (53.7%) |
  Female | 19 (46.3%) |
 Mean age(y)* | 54.4 ± 10.2 (32.0, 71.0) |
 BMI (kg/m2)* | 27.8 ± 4.3 (18.4, 33.1) |
NC regimen | |
 FOLFOX | 20 (48.7%) |
 FOLFOX and cetuximab | 4 (9.8%) |
 FOLFIRI | 13 (31.7%) |
 FOLFIRI and bevacizumab | 4 (9.8%) |
CASH scores | |
 Grade 0 | 8 (19.5%) |
 Grade 1 | 22 (53.7%) |
 Grade 2 | 11 (26.8%) |
 Grade 3 | – |
CASH scores | |
 Grade 0 | 10 (24.4%) |
 Grade 1 | 23 (56.1%) |
 Grade 2 | 8 (9.76%) |
 Grade 3 | – |
CASH & SOS scores | |
 Grade 0 | 7 (17.1%) |
 Grade 1 | 23 (56.1%) |
 Grade 2 | 11 (26.8%) |
 Grade 3 |  |